Table 1 Demographic and clinical characteristics of patients randomized at Day 0.
From: Impact of oxygen tension according to embryo stage of development: a prospective randomized study
Group A 20% O2 (n = 265) | Group B 5% O2 (n = 508) | |
|---|---|---|
Female age (y) | 32.8 (4.1) | 32.9 (4.3) |
Male age (y) | 36.3 (6.4) | 36.9 (6.8) |
Female BMI (kg/m2) | 24.5 (4.4) | 24.7 (4.2) |
Male BMI (kg/m2) | 26.4 (4.0) | 26.1 (4.3) |
Smoking (female), n (%) | ||
Yes | 54 (22.0) | 80 (17.0) |
Antral follicle count (n) | ||
AMH (ng/mL) | 4.2 (3.1) | 4.2 (5.0) |
Day 3 FSH (IU/L) | 6.7 (2.1) | 6.6 (2.2) |
Ovarian function, n (%) | ||
Normal | 214 (86.0) | 389 (83.0) |
Infertility duration (y) | 4.4 (2.2) | 4.7 (2.7) |
Cause of infertility, n (%) | ||
Female | 138 (48.0) | 252 (50.0) |
Male | 94 (35.0) | 219 (43.0) |
Idiopathic | 74 (28.0) | 105 (21.0) |
Stimulation protocol (%) | ||
Antagonist | 238 (90.0) | 433 (85.0) |
Total FSH dose administered (IU) | 2319 (1102) | 2582 (1228)* |
Estradiol day hCG (pg/mL) | 2604 (1399) | 2457 (1241) |
Progesterone day hCG (pg/mL) | 1.0 (0.6) | 1.0 (0.8) |
Endometrium thickness (mm) | 10.3 (2.4) | 10.7 (2.6) |
